These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3720211)

  • 21. Microparticulate-induced phlebitis. Its prevention by in-line filtration.
    Falchuk KH; Peterson L; McNeil BJ
    N Engl J Med; 1985 Jan; 312(2):78-82. PubMed ID: 3880597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histopathology and bacteriology of postinfusion phlebitis.
    Ghidyal SK; Pande RC; Misra TR
    Int Surg; 1975; 60(6-7):341-2. PubMed ID: 1150378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postinfusion phlebitis.
    Thomas ET; Evers W; Racz GB
    Anesth Analg; 1970; 49(1):150-9. PubMed ID: 5461063
    [No Abstract]   [Full Text] [Related]  

  • 24. Infusion phlebitis in medical and surgical patients in Siriraj Hospital.
    Danchaivijitr S; Srihapol N; Pakaworawuth S
    J Med Assoc Thai; 1995 Jul; 78 Suppl 2():S91-4. PubMed ID: 7561603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between continuous peripheral i.v. infusion of 3% sodium chloride injection and phlebitis in adults.
    Meng L; Nguyen CM; Patel S; Mlynash M; Caulfield AF
    Am J Health Syst Pharm; 2018 Mar; 75(5):284-291. PubMed ID: 29472509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predisposing factors to phlebitis in patients with peripheral intravenous catheters: a descriptive study.
    Uslusoy E; Mete S
    J Am Acad Nurse Pract; 2008 Apr; 20(4):172-80. PubMed ID: 18387013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Administrating incompatible drugs by a retrograde intravenous infusion system.
    Johnson CE; Roesner MP; Berman JR; Burch KJ
    Am J Hosp Pharm; 1985 Jan; 42(1):109-11. PubMed ID: 2982257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double-blind evaluation of 5-mum final filtration to reduce postinfusion phlebitis.
    Evans WE; Barker LF; Simone JV
    Am J Hosp Pharm; 1976 Nov; 33(11):1160-3. PubMed ID: 998633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of syringe size on bruising following subcutaneous heparin injection.
    Hadley SA; Chang M; Rogers K
    Am J Crit Care; 1996 Jul; 5(4):271-6. PubMed ID: 8811149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stability of diluted heparin sodium stored in plastic syringes.
    Tunbridge LJ; Lloyd JV; Penhall RK; Wise AL; Maloney T
    Am J Hosp Pharm; 1981 Jul; 38(7):1001-4. PubMed ID: 7258195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Particulate matter assessment of a clinical investigation on filtration and infusion phlebitis.
    Schroeder HG; DeLuca PP
    Am J Hosp Pharm; 1976 Jun; 33(6):543-6. PubMed ID: 1274972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A financial evaluation of the Becton Dickinson 360 infuser system.
    Fiorenzo VJ; Kelly WN
    Hosp Pharm; 1987 Jun; 22(6):563-6. PubMed ID: 10312122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripheral vein infusion of dextrose/amino acid solutions +/- 20% fat emulsion.
    Daly JM; Masser E; Hansen L; Canham JE
    JPEN J Parenter Enteral Nutr; 1985; 9(3):296-9. PubMed ID: 4009919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stability and availability of cyclosporine in 5% dextrose injection or 0.9% sodium chloride injection.
    Ptachcinski RJ; Logue LW; Burckart GJ; Venkataramanan R
    Am J Hosp Pharm; 1986 Jan; 43(1):94-7. PubMed ID: 3953588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maximum tolerated osmolarity for peripheral administration of parenteral nutrition in pediatric patients.
    Dugan S; Le J; Jew RK
    JPEN J Parenter Enteral Nutr; 2014 Sep; 38(7):847-51. PubMed ID: 23851423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An evaluation of patient preference for an alternative insulin delivery system compared to standard vial and syringe.
    Stockl K; Ory C; Vanderplas A; Nicklasson L; Lyness W; Cobden D; Chang E
    Curr Med Res Opin; 2007 Jan; 23(1):133-46. PubMed ID: 17257475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Risk factors for the development of phlebitis in peripheral infusions].
    Klaver NS; Hermans J; Ulrich C
    Ned Tijdschr Geneeskd; 1998 Feb; 142(8):405-9. PubMed ID: 9562775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of two different short peripheral catheter materials on phlebitis development.
    Karadağ A; Görgülü S
    J Intraven Nurs; 2000; 23(3):158-66. PubMed ID: 11272972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The importance of frequent examination of infusion sites in preventing postinfusion phlebitis.
    Arnold RE; Elliot EK; Holmes BH
    Surg Gynecol Obstet; 1977 Jul; 145(1):19-20. PubMed ID: 877819
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.